ArticleJournal of Cancer2025

TACE Empowers Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors in Unresectable HCC: A Multicenter Retrospective Study.

Yu Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.